These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31619256)

  • 1. NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis.
    Saga K; Park J; Nimura K; Kawamura N; Ishibashi A; Nonomura N; Kaneda Y
    J Exp Clin Cancer Res; 2019 Oct; 38(1):416. PubMed ID: 31619256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 in acute myeloid leukemia facilitates natural killer cell-mediated surveillance.
    Witalisz-Siepracka A; Denk CM; Zdársky B; Hofmann L; Edtmayer S; Harm T; Weiss S; Heindl K; Hessenberger M; Summer S; Dutta S; Casanova E; Obermair GJ; Győrffy B; Putz EM; Sill H; Stoiber D
    Front Immunol; 2024; 15():1374068. PubMed ID: 39034990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NANOG expression in human development and cancerogenesis.
    Grubelnik G; Boštjančič E; Pavlič A; Kos M; Zidar N
    Exp Biol Med (Maywood); 2020 Mar; 245(5):456-464. PubMed ID: 32041418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent loss of HAPLN1 erodes vascular integrity via indirect upregulation of endothelial ICAM1 in melanoma.
    Marino-Bravante GE; Carey AE; Hüser L; Dixit A; Wang V; Kaur A; Liu Y; Ding S; Schnellmann R; Gerecht S; Gu L; Eisinger-Mathason TSK; Chhabra Y; Weeraratna AT
    Nat Aging; 2024 Mar; 4(3):350-363. PubMed ID: 38472454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells for cancer immunotherapy.
    Shimasaki N; Jain A; Campana D
    Nat Rev Drug Discov; 2020 Mar; 19(3):200-218. PubMed ID: 31907401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer.
    Taftaf R; Liu X; Singh S; Jia Y; Dashzeveg NK; Hoffmann AD; El-Shennawy L; Ramos EK; Adorno-Cruz V; Schuster EJ; Scholten D; Patel D; Zhang Y; Davis AA; Reduzzi C; Cao Y; D'Amico P; Shen Y; Cristofanilli M; Muller WA; Varadan V; Liu H
    Nat Commun; 2021 Aug; 12(1):4867. PubMed ID: 34381029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer.
    Zhou Q; Xu J; Xu Y; Sun S; Chen J
    Front Immunol; 2023; 14():1176647. PubMed ID: 37671167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.
    Kerdivel G; Amrouche F; Calmejane MA; Carallis F; Hamroune J; Hantel C; Bertherat J; Assié G; Boeva V
    Clin Epigenetics; 2023 Aug; 15(1):121. PubMed ID: 37528470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer.
    Lin M; Sun X; Lv L
    Mol Ther Oncolytics; 2023 Jun; 29():91-106. PubMed ID: 37215386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity.
    Dos Reis FD; Jerónimo C; Correia MP
    Front Immunol; 2023; 14():1152572. PubMed ID: 37090711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Developmental Origins of Cancer: A Review of the Genes Expressed in Embryonic Cells with Implications for Tumorigenesis.
    Balachandran S; Narendran A
    Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Roles of Nanog in Cancer Cells and Their Extracellular Vesicles.
    Saito M
    Cells; 2022 Dec; 11(23):. PubMed ID: 36497144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism underlying circRNA dysregulation in the TME of digestive system cancer.
    Wu Z; Yu X; Zhang S; He Y; Guo W
    Front Immunol; 2022; 13():951561. PubMed ID: 36238299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NANOG Promotes Cell Proliferation, Invasion, and Stemness via IL-6/STAT3 Signaling in Esophageal Squamous Carcinoma.
    Deng L; Zhang X; Xiang X; Xiong R; Xiao D; Chen Z; Liu K; Feng G
    Technol Cancer Res Treat; 2021; 20():15330338211038492. PubMed ID: 34520294
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of Several Pathways for Efficient Killing of Prostate Cancer Stem Cells: A Central Role of NF-κB RELA.
    Witte KE; Pfitzenmaier J; Storm J; Lütkemeyer M; Wimmer C; Schulten W; Czaniera N; Geisler M; Förster C; Wilkens L; Knabbe C; Mertzlufft F; Kaltschmidt B; Am Esch JS; Kaltschmidt C
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?
    Wu J
    Crit Rev Immunol; 2021; 41(2):101-106. PubMed ID: 34348004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
    Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
    Front Oncol; 2021; 11():601668. PubMed ID: 34123777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPS364, a Novel Deep-Sea Bacterial Exopolysaccharide, Inhibits Liver Cancer Cell Growth and Adhesion.
    Wang Y; Liu G; Liu R; Wei M; Zhang J; Sun C
    Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33809909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple method using CRISPR-Cas9 to knock-out genes in murine cancerous cell lines.
    Ishibashi A; Saga K; Hisatomi Y; Li Y; Kaneda Y; Nimura K
    Sci Rep; 2020 Dec; 10(1):22345. PubMed ID: 33339985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy.
    Venkatraman S; Meller J; Hongeng S; Tohtong R; Chutipongtanate S
    Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33291616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.